Taken together, our results show that GSDMD deficiency ameliorates hyperoxia-induced BPD and ROP in mouse models and reveal novel GSDMD-regulated gene pathways that are critical in the development and progression of BPD and ROP. Here, GSDMD is linked to bronchopulmonary dysplasia.